DexCom, Inc. (DXCM)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
Yesterday 6:56 PM
View: 
Doubleday Richard
EVP, Chief Commercial Officer
DexCom, Inc. (DXCM) 23-Jun-17Market Sale (Planned) 3,187$78.22$249,273.00(3%)
101.0K to 97.81K
3%
Yesterday 6:55 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) 23-Jun-17Market Sale (Planned) 1,450$78.19$113,378.00(1%)
114.97K to 113.52K
2%
13-Jun-17 5:27 PM
View: 
Balo Andrew K
EVP, Clinical and Regulatory
DexCom, Inc. (DXCM) 12-Jun-17Market Sale (Planned) 3,200$69.06$220,989.00(3%)
109.63K to 106.43K
< 1%
13-Jun-17 5:26 PM
View: 
Sayer Kevin R
President & CEO
Director
DexCom, Inc. (DXCM) 12-Jun-17Market Sale (Planned) 6,000$69.07$414,411.00(2%)
338.68K to 332.68K
< 1%
05-Jun-17 8:50 PM
View: 
Kahn Barbara
Director
DexCom, Inc. (DXCM) 01-Jun-17Grant 4,353$0.00$4.3517%
26.09K to 30.45K
05-Jun-17 8:50 PM
View: 
Skyler Jay S
Director
DexCom, Inc. (DXCM) 01-Jun-17Grant 4,553$0.00$4.5514%
32.26K to 36.81K
05-Jun-17 8:49 PM
View: 
Augustinos Nicholas
Director
DexCom, Inc. (DXCM) 01-Jun-17Grant 4,353$0.00$4.3516%
26.66K to 31.02K
05-Jun-17 8:47 PM
View: 
Altman Steven R
Director
DexCom, Inc. (DXCM) 01-Jun-17Grant 4,353$0.00$4.3519%
23.5K to 27.86K
05-Jun-17 8:47 PM
View: 
Topol Eric
Director
DexCom, Inc. (DXCM) 01-Jun-17Grant 4,653$0.00$4.655%
99.91K to 104.56K
05-Jun-17 8:02 PM
View: 
Abbey Donald
EVP Quality
DexCom, Inc. (DXCM) 01-Jun-17Disposition 7,784$66.38$516,707.00(9%)
82.51K to 74.73K
(3%)
05-Jun-17 8:48 PM
View: 
Collins Richard Alexander
Director
DexCom, Inc. (DXCM) 01-Jun-17Grant 5,355$0.00$5.361071%
0.5K to 5.86K
05-Jun-17 8:48 PM
View: 
Foletta Mark G
Director
DexCom, Inc. (DXCM) 01-Jun-17Grant 4,952$0.00$4.9532%
15.64K to 20.59K
26-May-17 4:24 PM
View: 
Gregg Terrance H
Executive Chairman
Director
DexCom, Inc. (DXCM) 24-May-17Option Exercise 30,000$6.85$205,500.006%
506.9K to 536.9K
25-May-17 7:15 PM
View: 
Doubleday Richard
EVP, Chief Commercial Officer
DexCom, Inc. (DXCM) 23-May-17Market Sale (Planned) 3,182$68.29$217,290.00(3%)
104.18K to 101.0K
< 1%
25-May-17 7:16 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) 23-May-17Market Sale (Planned) 1,450$68.24$98,949.00(1%)
116.42K to 114.97K
< 1%
18-May-17 5:46 PM
View: 
Sayer Kevin R
President & CEO
Director
DexCom, Inc. (DXCM) 17-May-17Market Option Sale (Planned) 3,649$68.39$249,563.00(1%)
347.33K to 343.68K
18-May-17 5:46 PM
View: 
Sayer Kevin R
President & CEO
Director
DexCom, Inc. (DXCM) 17-May-17Option Exercise 3,649$8.79$32,074.701%
343.68K to 347.33K
18-May-17 5:46 PM
View: 
Sayer Kevin R
President & CEO
Director
DexCom, Inc. (DXCM) 17-May-17Market Sale (Planned) 5,000$68.39$341,961.00(1%)
343.68K to 338.68K
17-May-17 7:36 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) 16-May-17Gift 1,000----(< 1%)
117.42K to 116.42K
12-May-17 6:19 PM
View: 
Balo Andrew K
EVP, Clinical and Regulatory
DexCom, Inc. (DXCM) 10-May-17Market Sale (Planned) 3,200$71.93$230,176.00(3%)
112.83K to 109.63K
4%
26-Apr-17 7:04 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) 24-Apr-17Market Sale (Planned) 1,450$75.89$110,041.00(1%)
118.87K to 117.42K
1%
26-Apr-17 7:04 PM
View: 
Doubleday Richard
EVP, Chief Commercial Officer
DexCom, Inc. (DXCM) 24-Apr-17Market Sale (Planned) 3,182$75.78$241,131.00(3%)
107.37K to 104.18K
1%
24-Apr-17 6:13 PM
View: 
Gregg Terrance H
Executive Chairman
Director
DexCom, Inc. (DXCM) 20-Apr-17Market Sale 15,000$74.10$1,111,500.00(3%)
521.9K to 506.9K
(2%)
19-Apr-17 5:20 PM
View: 
Sayer Kevin R
President & CEO
Director
DexCom, Inc. (DXCM) 17-Apr-17Option Exercise 10,000$8.79$87,900.003%
343.68K to 353.68K
19-Apr-17 5:20 PM
View: 
Sayer Kevin R
President & CEO
Director
DexCom, Inc. (DXCM) 17-Apr-17Market Option Sale (Planned) 10,000$75.63$756,317.00(3%)
353.68K to 343.68K
12-Apr-17 5:31 PM
View: 
Balo Andrew K
EVP, Clinical and Regulatory
DexCom, Inc. (DXCM) 10-Apr-17Market Sale (Planned) 3,200$78.19$250,208.00(3%)
116.03K to 112.83K
1%
24-Mar-17 5:53 PM
View: 
Doubleday Richard
EVP, Chief Commercial Officer
DexCom, Inc. (DXCM) 23-Mar-17Market Sale (Planned) 3,182$76.38$243,029.00(3%)
110.55K to 107.37K
(11%)
24-Mar-17 5:54 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) 23-Mar-17Market Sale (Planned) 3,987$76.25$304,006.00(3%)
122.86K to 118.87K
(11%)
24-Mar-17 5:53 PM
View: 
Roper Jess
SVP, CFO
DexCom, Inc. (DXCM) 22-Mar-17Market Sale (Planned) 2,000$75.97$151,937.00(4%)
56.95K to 54.95K
(12%)
21-Mar-17 6:03 PM
View: 
Sayer Kevin R
President & CEO
Director
DexCom, Inc. (DXCM) 17-Mar-17Option Exercise 10,000$8.79$87,900.003%
343.68K to 353.68K
21-Mar-17 6:03 PM
View: 
Sayer Kevin R
President & CEO
Director
DexCom, Inc. (DXCM) 17-Mar-17Market Option Sale (Planned) 10,000$77.82$778,158.00(3%)
353.68K to 343.68K
(9%)
15-Mar-17 8:40 PM
View: 
Leach Jacob Steven
SVP, Research & Development
DexCom, Inc. (DXCM) 14-Mar-17Market Sale 3,050$77.32$235,824.00(2%)
147.31K to 144.25K
(10%)
16-Mar-17 6:04 PM
View: 
Kahn Barbara
Director
DexCom, Inc. (DXCM) 14-Mar-17Market Sale 3,000$77.36$232,080.00(10%)
29.09K to 26.09K
(10%)
15-Mar-17 8:40 PM
View: 
Leach Jacob Steven
SVP, Research & Development
DexCom, Inc. (DXCM) 13-Mar-17Market Sale 7,926$77.97$617,991.00(5%)
155.23K to 147.31K
(9%)
14-Mar-17 7:59 PM
View: 
Valdes Jorge A
CTO
DexCom, Inc. (DXCM) 13-Mar-17Market Sale (Planned) 14,400$77.74$1,119,510.00(24%)
58.92K to 44.52K
(9%)
14-Mar-17 7:58 PM
View: 
Moy Jeffrey
SVP, Operations
DexCom, Inc. (DXCM) 10-Mar-17Acquisition (other) 26,001$78.24$2,034,320.0012%
210.6K to 236.6K
8%
15-Mar-17 8:40 PM
View: 
Leach Jacob Steven
SVP, Research & Development
DexCom, Inc. (DXCM) 10-Mar-17Option Exercise 7,500$7.63$57,225.005%
157.69K to 165.19K
14-Mar-17 7:59 PM
View: 
Valdes Jorge A
CTO
DexCom, Inc. (DXCM) 10-Mar-17Acquisition (other) 32,001$78.24$2,503,760.0042%
75.83K to 107.83K
8%
10-Mar-17 8:48 PM
View: 
Gregg Terrance H
Executive Chairman
Director
DexCom, Inc. (DXCM) 10-Mar-17Disposition 16,173$77.55$1,254,230.00(3%)
538.08K to 521.9K
(9%)
14-Mar-17 7:58 PM
View: 
Roper Jess
SVP, CFO
DexCom, Inc. (DXCM) 10-Mar-17Disposition 9,606$77.55$744,951.00(14%)
66.56K to 56.95K
(9%)
14-Mar-17 7:58 PM
View: 
Moy Jeffrey
SVP, Operations
DexCom, Inc. (DXCM) 10-Mar-17Disposition (other) 26,001$78.24$2,034,320.00(12%)
224.71K to 198.71K
(8%)
10-Mar-17 8:45 PM
View: 
Murphy Patrick Michael
VP, Legal Aff & Chf Compl Ofcr
DexCom, Inc. (DXCM) 10-Mar-17Disposition 6,036$77.55$468,095.00(15%)
40.49K to 34.45K
(9%)
14-Mar-17 7:59 PM
View: 
Valdes Jorge A
CTO
DexCom, Inc. (DXCM) 10-Mar-17Disposition 6,254$77.55$485,001.00(6%)
107.83K to 101.58K
(9%)
14-Mar-17 7:59 PM
View: 
Valdes Jorge A
CTO
DexCom, Inc. (DXCM) 10-Mar-17Disposition (other) 32,001$78.24$2,503,760.00(35%)
90.92K to 58.92K
(8%)
10-Mar-17 8:49 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) 10-Mar-17Disposition 15,058$77.55$1,167,760.00(11%)
137.92K to 122.86K
(9%)
14-Mar-17 7:57 PM
View: 
Balo Andrew K
EVP, Clinical and Regulatory
DexCom, Inc. (DXCM) 10-Mar-17Disposition 13,430$77.55$1,041,500.00(10%)
132.66K to 119.23K
(9%)
10-Mar-17 8:49 PM
View: 
Lister John
General Manager, EMEA
DexCom, Inc. (DXCM) 10-Mar-17Disposition 9,698$77.55$752,086.00(10%)
93.73K to 84.03K
(9%)
14-Mar-17 7:57 PM
View: 
Balo Andrew K
EVP, Clinical and Regulatory
DexCom, Inc. (DXCM) 10-Mar-17Market Sale (Planned) 3,200$77.71$248,672.00(3%)
119.23K to 116.03K
(9%)
14-Mar-17 7:58 PM
View: 
Moy Jeffrey
SVP, Operations
DexCom, Inc. (DXCM) 10-Mar-17Disposition 11,893$77.55$922,309.00(5%)
236.6K to 224.71K
(9%)
15-Mar-17 8:40 PM
View: 
Leach Jacob Steven
SVP, Research & Development
DexCom, Inc. (DXCM) 10-Mar-17Disposition 9,961$77.55$772,482.00(6%)
165.19K to 155.23K
(9%)